Leader: Mark Pegram, M.D. University of California, Los Angeles
The workshop will cover issues regarding barriers to clinical trials, identifying
translational endpoints, development of targeted therapies, intellectual property
and the impact of HIPPA. Workshop is geared toward audience members not normally
involved with clinical trials.